Jennifer Vande Voort
Psychiatrist at Mayo Clinic in Rochester, Minnesota
Data updated
Research Footprint
Jennifer Vande Voort appears in 6 tracked papers (2014–2023), most studied alongside Ketamine, across Depressive Disorders, Suicidality and Bipolar Disorder.
Most-cited paper: Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety (283 citations).
Frequent co-authors: Carlos Zarate, Mark John Niciu and Erica Richards.
Background & Research
Jennifer L. Vande Voort is a psychiatrist at Mayo Clinic in Rochester, Minnesota, with clinical and research interests in mood disorders, suicidal behavior, and adolescent depression. Her research has included ketamine for treatment-resistant depression, assessment of suicidal ideation in clinical trials, and outcome studies on rapid-acting antidepressants. Mayo Clinic materials also describe her as a clinician-researcher whose work spans child, adolescent, and adult psychiatry.
Key Impact
She is a Mayo Clinic clinician-researcher known for work on ketamine and esketamine in treatment-resistant depression, suicidal ideation, and rapid-acting antidepressant outcomes.
Collaboration Network
11 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jennifer Vande Voort is associated with.